Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model

Claudin-low triple negative breast cancer (CL-TNBC) is a clinically aggressive molecular TNBC subtype characterized by a propensity to metastasize, recur and acquire chemoresistance. CL-TNBC has a diverse intra- and extracellular composition and microenvironment, and currently there are no clinicall...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoscience
Glavni autori: Matossian, Margarite D., Burks, Hope E., Elliott, Steven, Hoang, Van T., Bowles, Annie C., Sabol, Rachel A., Bunnell, Bruce A., Martin, Elizabeth C., Burow, Matthew E., Collins-Burow, Bridgette M.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2018
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5978446/
https://ncbi.nlm.nih.gov/pubmed/29854878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncoscience.412
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items